Implementation of Guideline-Based Care in the Hospital Setting

Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.

Play the podcast in Apple Podcasts.

podcast player graphic

Episode 4 – Implementation of Guideline-Based Care in the Hospital Setting

Download the Episode 4 Transcript.

Jennifer B. Green, MD is a professor of medicine and endocrinologist at Duke University and the Duke Clinical Research Institute (DCRI). Her research has focused upon strategies to treat diabetes and reduce the risk of cardiovascular, renal and other complications. Her work with the DCRI has included leadership of several international trials designed to determine the cardiovascular effects of glucose-lowering medications (TECOS, EXSCEL, and Harmony Outcomes), and she is now the US coordinating center PI for the EMPA-Kidney trial.  Dr. Green is also a member of the ADA Professional Practice Committee, which publishes the annual Standards of Care in Diabetes.

Jennifer Green

Jennifer B. Green, MD

Neha J. Pagidipati, MD, MPH is an Assistant Professor of Medicine and cardiovascular disease prevention specialist.  Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management.  She is also building the Duke Cardiometabolic Disease Prevention Program, which focuses on behavior change and risk factor management in patients with high risk of cardiovascular and metabolic diseases such as diabetes and obesity.

doctor Neha J. Pagidipati, MD, MPH

Neha J. Pagidipati, MD, MPH